Stock-Based Compensation

$19.96M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$19.96Mperiod endingJun 30, 2026

IKT TTM Stock-Based Comp ($1.44M → $19.96M)

TTM stock-based compensation

High-resolution chart · PNG

IKT stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Inhibikase Therapeutics Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	19,964,762
Mar 31, 2026	18,827,494
Dec 31, 2025	15,309,924
Sep 30, 2025	18,684,606
Jun 30, 2025	14,307,424
Mar 31, 2025	10,129,379
Dec 31, 2024	8,140,617
Sep 30, 2024	354,404
Jun 30, 2024	336,161
Mar 31, 2024	430,309
Dec 31, 2023	500,148
Sep 30, 2023	478,262
Jun 30, 2023	450,269
Mar 31, 2023	458,191
Dec 31, 2022	458,147
Sep 30, 2022	623,634
Jun 30, 2022	874,265
Mar 31, 2022	1,063,981
Dec 31, 2021	1,531,876
Sep 30, 2021	1,420,446
Jun 30, 2021	1,207,785
Mar 31, 2021	885,302
Dec 31, 2020	433,936
Sep 30, 2020	419,875
Jun 30, 2020	1,152,143
Mar 31, 2020	1,243,233
Dec 31, 2019	1,436,608
Sep 30, 2019	1,462,823
Jun 30, 2019	665,982